Skip to main content
Clinical Trials/JPRN-UMIN000051053
JPRN-UMIN000051053CompletedUnknown

Primary Mycetoma of The Calcaneum - Primary Mycetoma of The Calcaneum

KEM0 sites1 target enrollmentStarted: July 7, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
KEM
Enrollment
1

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
12years-old to 12years-old (—)
Sex
Female

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor
KEM

Similar Trials

Active, not recruiting
Not Applicable
Evaluation of factors that worsen survival in metastatic patients of skin carcinomaimmunosuppressionsurgerytransplantationnomogramsQ65.070.010squamous cell carcinomaE02.095.465.425.450Q65.070C04.557.470.200.400E01.789.650
RBR-9wt2wjGiulianno Molina de Melo
Active, not recruiting
Not Applicable
Skin cancer with spread to the parotid: evaluation of factors that worsen the clinical pictureskin neoplasmsprognosisparotid neoplasmssalivary gland diseasesC04.588.805E01.789C04.588.443.591.824.695C07.465.815
RBR-36vxx7Giulianno Molina de Melo
Active, not recruiting
Phase 1
Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis (sun spots) treated with ingenol disoxate gel or vehicleMedDRA version: 20.0 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic Keratosis
EUCTR2017-000228-85-GBEO Pharma A/S563
Active, not recruiting
Phase 1
Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis (sun spots) treated with ingenol disoxate gel or vehicleMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic Keratosis
EUCTR2017-000228-85-DEEO Pharma A/S850
Not yet recruiting
Not Applicable
Study of skin features, laboratory features and response to treatment to antifungal drugs in patients with superficial fungal infections.
CTRI/2018/04/013045MAHARAJAHS INSTITUTE OF MEDICAL SCIENCES
Primary Mycetoma of The Calcaneum: Case... | Clinical Trial